![Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal](https://media.bizj.us/view/img/10777492/47002105ovaleap300ie-0-5ml*750xx640-360-0-60.jpg)
Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal
![Teva's generic of LoSeasonique® Tablets: Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) Teva's generic of LoSeasonique® Tablets: Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)](https://www.tevagenerics.com/globalassets/products/image//C-D/Camr6148.jpg)
Teva's generic of LoSeasonique® Tablets: Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
![Seasonique and Seasonale Lawsuit Filed, Claiming Birth Control Pills Caused Liver Tumors - AboutLawsuits.com Seasonique and Seasonale Lawsuit Filed, Claiming Birth Control Pills Caused Liver Tumors - AboutLawsuits.com](https://gwick42bmpq1joaxl1a0cctp-wpengine.netdna-ssl.com/wp-content/uploads/resized/courthouse_ss_450265684-1000x0-c-default.jpg)
Seasonique and Seasonale Lawsuit Filed, Claiming Birth Control Pills Caused Liver Tumors - AboutLawsuits.com
![Teva Announces Sale of Remaining Assets in Specialty Global Women's Health Portfolio for $1.38 Billion – Sawaya Partners., LLC Teva Announces Sale of Remaining Assets in Specialty Global Women's Health Portfolio for $1.38 Billion – Sawaya Partners., LLC](https://www.sawayapartners.com/wp-content/uploads/2017/11/Teva-1170x560.jpg)